Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study | LANCET ONCOLOGY |